CLASSICAL HODGKIN LYMPHOMA
Clinical trials for CLASSICAL HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new CLASSICAL HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for CLASSICAL HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major trial aims to cure kids with lymphoma while reducing radiation
⭐️ CURE ⭐️ CompletedThis large international study tested whether we can safely use less radiation and adjust chemotherapy for children and teens with classical Hodgkin lymphoma without lowering cure rates. Over 2,900 newly diagnosed patients under 18 (and up to 25 in some countries) took part. The …
Matched conditions: CLASSICAL HODGKIN LYMPHOMA
Phase: PHASE3 • Sponsor: University of Giessen • Aim: ⭐️ CURE ⭐️
Last updated May 11, 2026 20:49 UTC
-
New drug shows promise for Hard-to-Treat hodgkin lymphoma
Disease control CompletedThis study tested a drug called tislelizumab in 46 people whose Hodgkin lymphoma had come back or didn't respond to prior treatments. The goal was to see if the drug could shrink or eliminate tumors. Participants received the drug until their disease worsened or side effects beca…
Matched conditions: CLASSICAL HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: BeiGene • Aim: Disease control
Last updated May 17, 2026 05:45 UTC
-
New combo therapy aims to stop hodgkin lymphoma relapse after transplant
Disease control CompletedThis study tested whether giving the drug brentuximab vedotin for up to a year after a stem cell transplant could help control Hodgkin lymphoma that had returned or not responded to treatment. Fourteen adults took part. The goal was to see if this approach could lower the chance …
Matched conditions: CLASSICAL HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: University of Cologne • Aim: Disease control
Last updated May 17, 2026 05:44 UTC
-
Blood mutation may reveal hidden lymphoma
Knowledge-focused CompletedThis study looked at whether a specific genetic change (XPO1 E571K) found in the blood of people with classical Hodgkin lymphoma can help doctors find leftover cancer after treatment. Researchers tested blood samples from 137 newly diagnosed patients before and after chemotherapy…
Matched conditions: CLASSICAL HODGKIN LYMPHOMA
Phase: NA • Sponsor: Centre Henri Becquerel • Aim: Knowledge-focused
Last updated May 11, 2026 20:52 UTC